Billionaire Steve Cohen Aggressively Bought These 5 Stocks Recently

In this piece, we will take a look at the five stocks that billionaire Steve Cohen bought aggressively recently. If you want to take a deeper dive into the billionaire’s hedge fund and the latest news, then check out Billionaire Steve Cohen Aggressively Bought These 12 Stocks Recently.

5. Sight Sciences, Inc. (NASDAQ:SGHT)

Point72’s Q3 2023 Investment: $515,273

Percentage Growth in Stake: 1,274,067%

Sight Sciences, Inc. (NASDAQ:SGHT) is an American medical devices company whose products help surgeons and patients with procedures involving the human eye. The tail end of 2023 proved to be tricky for its Glaucoma division due to complications about insurance coverage. Yet, Sight Sciences, Inc. (NASDAQ:SGHT)’s preliminary full year 2023 financial results still expect the firm to post a 14% annual revenue growth.

As of Q3 2023 end, eight out of the 910 hedge funds profiled by Insider Monkey were Sight Sciences, Inc. (NASDAQ:SGHT)’s shareholders. Daniel Sundheim’s D1 Capital Partners was the biggest investor among these as it owned a $19.7 million stake.

4. Qiagen N.V. (NYSE:QGEN)

Point72’s Q3 2023 Investment: $177 million

Percentage Growth in Stake: 1,454,624%

Qiagen N.V. (NYSE:QGEN) is a healthcare research company that works with firms and researchers that work with DNA, genes, bacteria, and other areas of medical research. The firm has beaten analyst EPS estimates in all four of its latest quarters and the shares are rated Buy on average.

During last year’s third quarter, 30 out of the 910 hedge funds part of Insider Monkey’s database had bought a stake in the company. Qiagen N.V. (NYSE:QGEN)’s largest hedge fund shareholder is Steve Cohen’s Point72 Asset Management due to its $177 million investment.

3. Nevro Corp. (NYSE:NVRO)

Point72’s Q3 2023 Investment: $5.3 million

Percentage Growth in Stake: 1,459,353%

Nevro Corp. (NYSE:NVRO) is a consumer medical devices company that makes and sells devices such as spinal cord stimulation systems for pain management. Its preliminary full-year 2023 results shared in January 2023 outlined a 5% annual revenue growth on the back of the strong performance of its diabetic neuropathy business division.

Insider Monkey’s September quarter of 2023 survey of 910 hedge funds discovered 22 Nevro Corp. (NYSE:NVRO) shareholders. Steven Boyd’s Armistice Capital was the biggest investor as it held $66.4 million worth of shares.

2. Axos Financial, Inc. (NYSE:AX)

Point72’s Q3 2023 Investment: $5.3 million

Percentage Growth in Stake: 1,573,400%

Axos Financial, Inc. (NYSE:AX) is an American regional bank headquartered in Las Vegas, Nevada. December 2023 was a crucial month for the firm as its shares jumped by 12% after Axos Financial, Inc. (NYSE:AX) announced that it is acquiring $1.25 billion of loan portfolios from the FDIC at a discount of 37%.

After digging through 910 hedge fund holdings for their third quarter of 2023 shareholdings, Insider Monkey found that 19 had held a stake in Axos Financial, Inc. (NYSE:AX).

1. Hibbett, Inc. (NASDAQ:HIBB)

Point72’s Q3 2023 Investment: $1.8 million

Percentage Growth in Stake: 1,939,800%

Hibbett, Inc. (NASDAQ:HIBB) is an American clothing company headquartered in Birmingham, Alabama. Its shares are rated Buy on average and analysts have set an average share price target of $69.75.

As of Q3 2023 end, 19 out of the 910 hedge funds covered by Insider Monkey’s research had bought the firm’s shares. Hibbett, Inc. (NASDAQ:HIBB)’s largest hedge fund shareholder is John Hempton’s Bronte Capital through its $28.8 million stake.

Disclosure: None. You can also take a look at These Dow Stocks Will Boost Their Dividends Soon and These Stocks under $10 Are Poised To Explode.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.